Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Engrailed-2 proposed as diagnostic biomarker for prostate cancer

June 10, 2010

Inhaled formoterol fumarate/glycopyrrolate is safe in healthy subjects

June 10, 2010

QBI-139 enters phase I trial in advanced/refractory solid tumors

June 10, 2010

Simvastatin/ezetimibe combination promotes tumor growth in prostate cancer model

June 10, 2010

Potent inhibitors identified of GIST-relevant kinases

June 10, 2010

Serum bilirubin modulates response to bucindolol in patients with heart failure

June 10, 2010

Bortezomib linked to heart failure in patients with multiple myeloma

June 9, 2010

NTx described as biomarker for prediction of bone metastasis in lung cancer

June 9, 2010

Antitumor agent MSC-1936369B shows safety in phase I trial

June 9, 2010

Arbaclofen placarbil improves sleep quality in PPI-responsive GERD

June 9, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...